Ngaphambi kokuba uphendule umbuzo othi "yintoni umgqomo wesifo somhlaza wesifo somhlaza wamaphaphu?" Kubalulekile ukuthetha malunga nawaphi amanani achaza izinga lokusinda. Okokuqala, wonke umntu uhlukile. Izibalo zitshilo ukuba yintoni inkambo "ephakathi" okanye ukusinda, kodwa abayitshiyo nantoni na ngabantu abathile. Zininzi izinto ezinokuchaphazela ukugxekwa kwe- squamous cell cell cancer.
Kwakhona kunceda ukugcina engqondweni ukuba iinkcukacha zisekelwe kwingcaciso eneminyaka emininzi ubudala. Njengoko unyango olutsha luyafumaneka, la manani awanakubonakalisa ngokuchanekileyo oko kuthethwa kwakho namhlanje. Ngokomzekelo, izinga lokusinda iminyaka emi-5 yomdlavuza wamaphaphu libikwe ngo-2017 lusekelwe kubantu abafumene unyango ngo-2012 nangaphambili. Ngelo xesha, kwakukho unyango olutsha olwamkelwe ukonyango lomhlaza wamaphaphu phakathi ko-2011 no-2016, kunokuba ngowama-40 kunyaka ngaphambi ko-2011. Kuthetha ukuthini ukuba amazinga okusinda kwangoku awanakucinga ukuba umntu uza kulindeleke ukuba kwenziwe nakweyiphi na lela machiza amatsha.
Kukho ithemba elininzi kulabo bafumene umdlavuza wamaphaphu namhlanje, kodwa ngelishwa, iifomanani oza kuzifunda akunakunceda ekuqondeni eli themba.
Izinto ezinokuthi zithinte i-Squamous Cell I-Lung Cancer Prognosis
Ezinye zezinto ezinokuchaphazela ixesha lokuphila kunye ne-squamous cell carcinoma ziquka:
- Isigaba somhlaza wakho - Isiqendu se -squamous cell carcinoma (umzekelo, isigaba 1 okanye isigaba sesi-2 ) sinokugqithiswa okungcono kunexesha elizayo (i- stage 3 okanye isigaba 4 ). Sekunjalo, gcinani engqondweni ukuba ezininzi zonyango lomhlaza olutsha oluxutyushwa ngasentla zilabo baqhubele umgangatho womhlaza wemiphunga.
- Abantu bakho abadala abakhulileyo abanomdlavuza wamaphaphu bahlala ixesha elide kunabantu asebekhulile abanomdlavuza wamaphaphu. Nangona kubalwa abantu, abantu abadala abakwenziyo kunye nabantu abaselula abanesi sifo, inkolelo yokuba umdlavuza wamaphaphu awukwazi ukuphathwa kubantu abadala. Enyanisweni, uphando lubone ukuba abadala asebekhulile benomdlavuza wamaphaphu bavame ukunyamezela unyango olufanayo lunconywayo kubantu abaselula abanesifo.
- Ubulili bakho - Ubomi bexesha lokuphila kwabasetyhini abanomdlavuza wamaphaphu liphezulu kwinqanaba ngalinye lesifo.
- Impilo yakho jikelele ngexesha lokuxilongwa - Ukuba uphila impilo yonke ngexesha lokuxilongwa kuhambelana nokulinda ixesha elide lokuphila, kunye nekhono elikhulu lokunyamekela unyango olunokunyusa ukusinda.
- Indlela osabela ngayo kunyango - Imiphumo emibi yezokwelapha ezifana nokuhlinzwa , i- chemotherapy , iipilisi ezijoliswe kuyo , i- immunotherapy , kunye neyeza zonyango ziyahluka phakathi kwabantu abahlukeneyo kwaye kunokunciphisa amandla akho okunyamezela unyango.
- Ezinye izimo zempilo onokuthi ube nazo - Ezinye izimo zempilo, ezifana ne- emphysema okanye isifo senhliziyo zinganciphisa ixesha lokuphila komhlaza wamaphaphu. Ezi ezinye iimeko ziyakwazi ukuphazamisa ezinye zezibonelelo zonyango lomhlaza. Ngokomzekelo, abo abane-COPD enamandla abanako ukunyamezela ukulahlekelwa i-lobe yemiphunga yabo kwimisebenzi yengqondo yomhlaza.
- Iingxaki zomdlavuza wamaphaphu - Iingxaki zomdlavuza wamaphaphu ezinjengeziphulo zegazi kunye nokunyanzeliswa kwesigxina, kunokunciphisa umdlavuza wokuphila komhlaza wamaphaphu. Kuyaphawuleka ukuba ezinye zezi ngxaki, ezinjengokudakumba, zinyango kakhulu, kwaye kubalulekile ukuphucula umhlala-mngeni, kubalulekile ukugxila kuphela ekuphatheni umdlavuza wamaphaphu kodwa iimeko zonyango eziqhelekileyo kunye nomdlavuza wamaphaphu.
- Yiba nenkqubo yokuxhasa - Izifundo zisitshela ukuba abo banesiseko soxhasano lwenhlalakahle banokuba neziphumo ezingcono kunezo ezingenayo. Ngenxa yeso sizathu, ukukhangela amaqela enkxaso yomdlavuza wamaphaphu kunye noluntu oluxhasayo lunokuchaphazela ukugxekwa kwakho. Nangona kunjalo, iingeniso zale ndawo zihlala ngaphaya kwenkxaso kuphela. Kukho abantu abaninzi abaye bafunda ngamanyango amatsha kunye novavanyo lweekliniki ezingekho kwiindawo zabo ze-oncologist, kodwa ekufundeni malunga nale nonyango njengengxenye yomdlavuza womdlavuza osebenzayo.
- Ukuba ngummeli wakho - Sifunda ukuba ukuba ngummeli wakho ekunyamekelweni komhlaza wakho akukwazi kuphela ukuphucula umgangatho wobomi kodwa kwenza ukubahluko phakathi kweziphumo.
Izibalo
Ukongeza kwimihluko phakathi kwabantu abahlukeneyo, ukuxela kwangaphambili kunokutshintsha ngexesha lokuba unyango olungcono lufumaneke njengoko kuphawuliwe kwangaphambili, kwaye ezo zonyango zonyango zifumaneka ngokukhawuleza.
I-Squamous cell carcinoma inokusasazeka kwizitho ezahlukileyo ezifana namathambo, izilonda ze-adrenal, isibindi, intlungu encinci okanye ubuchopho, kwaye ukuxela kwinqanaba eliphambili lalo mhlaza wesifo somhlaza akuyona into enhle. Oko kwathiwa, kukho abantu abasinde ixesha elide kunye nomdla wesifo somhlaza wesifo somhlaza wamangqamu, kwaye unyango olutsha, olunjengezilwanyana ezijoliswe kunyango kunye ne-immunotherapy, luqala ukuvumela abantu abathile ukuba baphile nomhlaza wesifo somhlaza njengesifo esingapheliyo.
Uninzi lwa manani lubonakalayo lubonakala kuzo zonke iintlobo zesifo somhlaza wesifo samasipha angasetyenzana. Phakathi kwezi zinto, i-squamous cell carcinoma i-squamous cell carcinoma iyancinci kuneleyo ye- adenocarcinoma kodwa ixhomekeke ngakumbi kunomdlavuza omkhulu wamangqamuzana .
Umlinganiselo weminyaka emi-5 yokusinda komhlaza wesifo somhlaza wamangqamu:
- Isigaba 1 - 49 ekhulwini kwisigaba 1A kunye neepesenti ezingama-45 kwisigaba 1B
- Isigaba sesi-2 - iipesenti ezingama-30 kwisigaba 2A kunye neepesenti ezingama-30 kwisigaba 2B
- Isigaba se-3 - i-14 ekhulwini kwi-3A kunye ne-5 ekhulwini kwi-3B yesigaba
- Isigaba 4 (iMetastatic) - malunga neepesenti ezili-1, nangona uphando lubonisa ukuba landa
Ngokwesigaba, ezinye izigulane ezingasetyenziswanga ngumhlaza weselpmous cell can be cured. Ngokuqhelekileyo, umdlavuza weselfamous squamous isasiphili kodwa kodwa unyango .
Uhlobo lwe-Chemotherapy, umzekelo, lunokuphucula ulondolozo kwaye luncede kunye neempawu zomdlavuza wemiphunga. Izifo ezininzi zonyango zivavanywa kwiimvavanyo zeclini , kwaye zinikeza ithemba lokuba i-squamous cell carcinoma yemiphunga yokuhlaziya iya kuphucula kwikamva. I-National Cancer Institute incoma ukuba wonke umntu onomdlavuza wamaphaphu kufuneka acinge ngethuba lokuhlolwa kwamachiza. Ngombulelo, ezininzi iinkqubo zomhlaza wemiphunga zisebenze ndawonye ukuze zenzele umlinganiselo wesifo somhlaza wamaphaphu wamahhala eenkonzo ezinxulumene nomntu onomdlavuza wamaphaphu avumelekileyo ukusebenzisa.
Ukuqikelela Ukuhlaziya Kwakho
Xa ukhangela ukuhlaziya kubalulekile ukuba uqaphele ukuba zonke iintsholongwane zomhlaza zesifo samaphaphu azifani. Enyanisweni, ukuba kukho abantu abangama-300 abanesifo se-squamous cell lung carcinoma egumbini, babeza kuba nama-cancer ekhethekileyo angama-300. Umhlaza wakho unokuba neempawu zee-molecular eziza kunyusa okanye ukunciphisa ukugxekwa kwakho ukuba i-oncologist yakho iya kuxoxa nawe. Ukongezelela, uphando lufuna ezinye iindlela zokuqikelela ukuxeliswa komntu othile we-squamous cell carcinoma ngokusekelwe kwiziphumo ezifana nokujikeleza iisilini ze-tumor ezifumaneka kwi- biopsy yamanzi kunye nokunye.
Ukuba usandul 'ukuvavanywa, mhlawumbi unokwesabisa, kwaye udibene kakhulu. Siye safunda ukuba ukuzifundisa ngomhlaza wakho, kwaye uzikhuthaze njengenxalenye yeqela lakho lononophelo lwezempilo, unokudlala indima enkulu ebomini bakho yobomi.
Khangela olu lwazi kumhlaza wesifo somhlaza wamangqamuzana, kuquka ezinye zezibonelelo zonyango ezisetyenziswayo.
Ngamanye amaxesha kunzima ukwazi apho uqala khona. Funda malunga namanyathelo okuqala oza kuthatha xa ufumanisa ukuba unomdlavuza wamaphaphu- iimpawu ezinokukunceda ekuhambeni lwakho.
Ukongezelela, qwa lasela ezi ngcebiso malunga noko abantu bangenza ngokwabo ukuphucula umdlavuza wamaphaphu .
Imithombo
American Cancer Society. Iingqinisiso zeK cancer kunye neenombolo 2016 .
Luo, X., Zang, X., Yang, L. et al. Uhlalutyo olusisigxina lwe-Computational Pathological Image Analysis Elixela ukuxilongwa kwe-Cancer Prognosis. Umbhalo we-Thoracic Oncology . 2016 Nov 4.
Qi, Y., kunye noWin Wang. Ukubaluleka kweeNtsholongwane zokuSasaza iisilini zeeSeli kwiSigamous Cell Lung Cancer Patients. ICancer Biomarkers . 2016 Dec 2.